Search

everythinglearnresearchcommunity

for

Search:↓

Many patients with lower urinary tract symptoms also have undiagnosed erectile dysfunction, which improves with treatment.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Patients follow treatment well, but many change medicines; good information helps compliance.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

Drinking alcohol 1-2 times a week may reduce urinary symptoms, but drinking more often might increase the risk.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Men with urinary symptoms are more likely to have erectile dysfunction, and there's a debate about research methods and authorship ethics.

Treatments for urinary symptoms often cause ejaculatory problems.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Saw palmetto extract is effective and safe for treating lower urinary tract symptoms, working as well as certain medications, and works even better in severe cases.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Metabolic syndrome worsens treatment outcomes for urinary symptoms in men with enlarged prostate.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

COVID-19 may affect reproductive and urinary systems, needing more research for better care.

SHPro® improved urinary symptoms and erectile function in men and is safe.

Higher testosterone and DHT levels are not linked to urinary symptoms in men.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Higher uric acid levels are linked to fewer urinary symptoms in healthy Korean men.